Rivaroxaban: a new treatment paradigm in the setting of vascular protection?

R Bauersachs, F Zannad - Thrombosis and Haemostasis, 2018 - thieme-connect.com
The pathophysiology of atherosclerosis involves a diseased endothelium, lipid accumulation
and low-grade inflammation. In later stages of coronary artery disease (CAD) and peripheral …

The coagulation system changes in patients with chronic heart failure

A Mongirdienė, L Kuršvietienė, A Kašauskas - Medicina, 2010 - mdpi.com
Though heart failure can mainly be caused by systolic or diastolic dysfunction, the
impairments of the neurohormonal, immune, and hemostatic systems are observed too …

Rationale and design of a randomized, double‐blind, event‐driven, multicentre study comparing the efficacy and safety of oral rivaroxaban with placebo for reducing …

F Zannad, B Greenberg, JGF Cleland… - European journal of …, 2015 - Wiley Online Library
Aims Thrombin is a critical element of crosstalk between pathways contributing to worsening
of established heart failure (HF). The aim of this study is to explore the efficacy and safety of …

慢性心力衰竭患者血清白介素6, 高敏C 反应蛋白和肿瘤坏死因子α 水平的变化及临床意义

朱海霞 - 中国全科医学, 2011 - cqvip.com
目的探讨白介素6 (IL-6), 高敏C 反应蛋白(Hs-CRP) 和肿瘤坏死因子α (TNF-α)
在慢性心力衰竭患者血清中水平的变化及其临床意义. 方法测定38 例正常人(对照组) 及95 …

Associations between fibrin D‐dimer, markers of inflammation, incident self‐reported mobility limitation, and all‐cause mortality in older men

SG Wannamethee, PH Whincup… - Journal of the …, 2014 - Wiley Online Library
Objectives To examine the independent relationships between fibrin D‐dimer, interleukin 6
(IL‐6), C‐reactive protein (CRP), and fibrinogen and incident mobility limitation and …

[HTML][HTML] A retrospective discussion of the prognostic value of combining prothrombin time (PT) and fibrinogen (Fbg) in patients with Hepatocellular carcinoma

XP Wang, MJ Mao, ZL He, L Zhang, PD Chi, J Su… - Journal of …, 2017 - ncbi.nlm.nih.gov
Aims: The levels of coagulation system tests have been studied in various cancers. In this
study, our aim is to evaluate the prognostic value of pretreatment plasma coagulation tests in …

Пациент с трансплантированным сердцем

СВ Готье, АО Шевченко, ВН Попцов - 2014 - elibrary.ru
Книга предназначена для врачей разных специальностей, наблюдающих пациентов с
пересаженным сердцем. В основу книги легли клинические рекомендации по ведению …

Prognostic Value of Prothrombin Time International Normalized Ratio in Acute Decompensated Heart Failure–A Combined Marker of Hepatic Insufficiency and …

A Okada, Y Sugano, T Nagai, S Takashio… - Circulation …, 2016 - jstage.jst.go.jp
Background: There are limited studies regarding the prognostic value of coagulation
abnormalities in heart failure patients. The clinical significance of prothrombin time …

Hemostatic biomarkers in dogs with chronic congestive heart failure

I Tarnow, T Falk, A Tidholm… - Journal of veterinary …, 2007 - Wiley Online Library
Background: Chronic congestive heart failure (CHF) in humans is associated with abnormal
hemostasis, and abnormalities in hemostatic biomarkers carry a poor prognosis. Alterations …

Procoagulant state in heart failure with preserved left ventricular ejection fraction

B Jug, N Vene, BG Salobir, M Šebeštjen… - International Heart …, 2009 - jstage.jst.go.jp
The impact of heart failure with preserved left ventricular ejection fraction (LVEF) on
activated hemostasis is still unclear. We sought to compare the activation of hemostasis in …